A detailed history of Group One Trading, L.P. transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 40,075 shares of CODX stock, worth $29,254. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,075
Previous 26,444 51.55%
Holding current value
$29,254
Previous $33,000 51.52%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.02 - $1.75 $13,903 - $23,854
13,631 Added 51.55%
40,075 $50,000
Q2 2024

Aug 14, 2024

BUY
$1.01 - $1.7 $9,696 - $16,320
9,600 Added 56.99%
26,444 $33,000
Q1 2024

May 10, 2024

BUY
$1.06 - $1.42 $5,830 - $7,810
5,500 Added 48.48%
16,844 $18,000
Q4 2023

Feb 14, 2024

BUY
$1.0 - $1.5 $11,200 - $16,800
11,200 Added 7777.78%
11,344 $15,000
Q3 2023

Nov 09, 2023

BUY
$1.03 - $1.85 $148 - $266
144 New
144 $0
Q4 2022

Feb 09, 2023

SELL
$2.32 - $3.68 $165,399 - $262,358
-71,293 Reduced 88.87%
8,926 $22,000
Q3 2022

Nov 09, 2022

SELL
$2.87 - $7.01 $51,657 - $126,172
-17,999 Reduced 18.33%
80,219 $258,000
Q2 2022

Aug 11, 2022

BUY
$3.76 - $6.29 $156,461 - $261,739
41,612 Added 73.51%
98,218 $551,000
Q1 2022

May 12, 2022

BUY
$5.03 - $9.61 $12,554 - $23,986
2,496 Added 4.61%
56,606 $350,000
Q4 2021

Feb 11, 2022

SELL
$8.12 - $10.37 $82,499 - $105,359
-10,160 Reduced 15.81%
54,110 $483,000
Q3 2021

Nov 12, 2021

BUY
$7.48 - $11.38 $148,358 - $225,710
19,834 Added 44.63%
64,270 $625,000
Q2 2021

Aug 10, 2021

SELL
$7.16 - $9.56 $175,262 - $234,009
-24,478 Reduced 35.52%
44,436 $367,000
Q1 2021

May 12, 2021

BUY
$8.52 - $19.21 $587,147 - $1.32 Million
68,914 New
68,914 $657,000

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $24.7M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.